nach oben

Erschienen in:

01.02.2024 | Research

Ozone therapy effect in medication-related osteonecrosis of the jaw as prevention or treatment: microtomographic, confocal laser microscopy and histomorphometric analysis

verfasst von: Maísa Pereira-Silva, Henrique Hadad, Laís Kawamata de Jesus, Maria Eduarda de Freitas Santana Oliveira, Juliano Milanezi de Almeida, Heloisa Helena Nímia, Osvaldo Magro Filho, Roberta Okamoto, Sérgio Bruzadelli Macedo, Celso Fernando Palmieri Junior, Francisley Ávila Souza

Erschienen in: Clinical Oral Investigations | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study aimed to evaluate the efficacy of ozone therapy in the preoperative (prevention) and/or postoperative (treatment) of MRONJ.

Material and methods

Forty male Wistar rats were caudally treated with zoledronic acid (ZOL) and to ozone therapy before extraction (prevention, POG), after extraction (treatment, TOG), or both (prevention and treatment, TPOG), and treated with saline (SAL). The animals received intramuscular fluorochrome (calcein and alizarin), and 28 days postoperatively, they were euthanized, and the tissues were subjected to microtomographic computed tomography (microCT), LASER confocal, and histomorphometric analyses.

Results

Micro-CT showed a higher bone volume fraction average in all groups than that in the ZOL group (P < 0.001), the ZOL group showed high porosity (P = 0.03), and trabecular separation was greater in the TOG group than in the POG group (P < 0.05). The mineral apposition rate of the POG group was high (20.46 ± 6.31) (P < 0.001), followed by the TOG group (20.32 ± 7.4). The TOG group presented the highest mean newly formed bone area (68.322 ± 25.296) compared with the ZOL group (P < 0.05), followed by the SAL group (66.039 ± 28.379) and ZOL groups (60.856 ± 28.425).

Conclusions

Ozone therapy modulated alveolar bone repair in animals treated with ZOL, mainly after surgery trauma, leading to bone formation as healing tissue.

Clinical relevance

Osteonecrosis has been a challenge in dentistry, and owing to the lack of a consensus regarding therapy, studies presenting new therapies are important, and ozone has been one of the therapies explored empirically.

Bocci V (2004) Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators Inflamm 13(1):3–11. https://doi.org/10.1080/0962935062000197083CrossRefPubMedPubMedCentral

Bocci VA (2006) Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res 37(4):425–435. https://doi.org/10.1016/j.arcmed.2005.08.006CrossRefPubMed

Bocci V, Aldinucci C (2006) Biochemical modifications induced in human blood by oxygenation-ozonation. J Biochem Mol Toxicol 20(3):133–138. https://doi.org/10.1002/jbt.20124CrossRefPubMed

Bocci V (2005) Ozone: a new medical drug, first edn. Springer Science & Business Media

Buyuk SK, Ramoglu SI, Sonmez MF (2016) The effect of different concentrations of topical ozone administration on bone formation in orthopedically expanded suture in rats. Eur J Orthod 38:281–285. https://doi.org/10.1093/ejo/cjv045CrossRefPubMed

Soares CD, Morais TML, Araújo RMFG, Meyer PF, Oliveira EAF, Silva RMV, Carreiro EM, Carreiro EP, Belloco VG, Mariz BALA, Jorge-Junior J (2019) Effects of subcutaneous injection of ozone during wound healing in rats. Growth Factors 37:95–103. https://doi.org/10.1080/08977194.2019.1643339CrossRefPubMed

Zhang J, Guan M, Xie C, Luo X, Zhang Q, Xue Y (2014) Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers. Oxid Med Cell Longev:273475. https://doi.org/10.1155/2014/273475

Travagli V, Zanardi I, Bernini P, Nepi S, Tenori L, Bocci V (2010) Effects of ozone blood treatment on the metabolite profile of human blood. Int J Toxicol 29(2):165–174. https://doi.org/10.1177/1091581809360069CrossRefPubMed

Viebahn-hänsler R, Fernández OS, Fahmy Z (2012) Ozone in medicine: the low-dose ozone concept: guidelines and treatment strategies. Ozone Sci Eng 34:408–424. https://doi.org/10.1080/01919512.2012.717847CrossRef

10.

Aljohani S, Fliefel R, Ihbe J, Kühnisch J, Ehrenfeld M, Otto S (2017) What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a systematic review. J Craniomaxillofac Surg 45(9):1493–1502. https://doi.org/10.1016/j.jcms.2017.05.028CrossRefPubMed

11.

Madrid C, Bouferrache K, Abarca M, Jaques B, Broome M (2010) Bisphosphonate-related osteonecrosis of the jaws: how to manage cancer patients. Oral Oncol 46(6):468–470. https://doi.org/10.1016/j.oraloncology.2010.03.016CrossRefPubMed

12.

Kushner GM, Alpert B (2011) Bisphosphonate-related osteonecrosis of the jaws. Curr Opin Otolaryngol Head Neck Surg 19(4):302–306. https://doi.org/10.1097/MOO.0b013e328348b257CrossRefPubMed

13.

Ruggiero SL (2011) Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci 1218:38–46. https://doi.org/10.1111/j.1749-6632.2010.05768.xADSCrossRefPubMed

14.

Bone HG, Chapurlat R, Brandi ML, Brown JP, Czerwinski E, Krieg MA, Mellström D, Radominski SC, Reginster JY, Resch H, Ivorra JA, Roux C, Vittinghoff E, Daizadeh NS, Wang A, Bradley MN, Franchimont N, Geller ML, Wagman RB et al (2013) The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension. J Clin Endocrinol Metab 98(11):4483–4492. https://doi.org/10.1210/jc.2013-1597CrossRefPubMedPubMedCentral

15.

Papapoulos S, Lippuner K, Roux C, Lin CJ, Kendler DL, Lewiecki EM, Brandi ML, Czerwiński E, Franek E, Lakatos P, Mautalen C, Minisola S, Reginster JY, Jensen S, Daizadeh NS, Wang A, Gavin M, Libanati C, Wagman RB, Bone HG (2015) The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study. Osteoporos Int 26(12):2773–2783. https://doi.org/10.1007/s00198-015-3234-7CrossRefPubMedPubMedCentral

16.

Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62(5):527–534. https://doi.org/10.1016/j.joms.2004.02.004CrossRefPubMed

17.

Woodis CB (2008) Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis. Ann Pharmacother 42(7):1085–1089. https://doi.org/10.1345/aph.1K652CrossRefPubMed

18.

Pazianas M (2011) Osteonecrosis of the jaw and the role of macrophages. J Natl Cancer Inst 103(3):232–240. https://doi.org/10.1093/jnci/djq516CrossRefPubMed

19.

Rasmusson L, Abtahi J (2014) Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment. Int J Dent 2014:471035. https://doi.org/10.1155/2014/471035CrossRefPubMedPubMedCentral

20.

Bagan J, Sáez GT, Tormos MC, Gavalda-Esteve C, Bagan L, Leopoldo-Rodado M, Calvo J, Camps C (2014) Oxidative stress in bisphosphonate-related osteonecrosis of the jaws. J Oral Pathol Med 43(5):371–377. https://doi.org/10.1111/jop.12151CrossRefPubMed

21.

Tamaoka J, Takaoka K, Hattori H, Ueta M, Maeda H, Yamamura M, Yamanegi K, Noguchi K, Kishimoto H (2019) Osteonecrosis of the jaws caused by bisphosphonate treatment and oxidative stress in mice. Exp Ther Med 17(2):1440–1448. https://doi.org/10.3892/etm.2018.7076CrossRefPubMed

22.

Wink DA, Grisham MB, Mitchell JB, Ford PC (1996) Direct and indirect effects of nitric oxide in chemical reactions relevant to biology. Methods Enzymol 268:12–31. https://doi.org/10.1016/s0076-6879(96)68006-9CrossRefPubMed

23.

Bilge A, Öztürk Ö, Adali Y, Üstebay S (2018) Could ozone treatment be a promising alternative for osteomyelitis? An experimental study. Acta Ortop Bras 26(1):67–71. https://doi.org/10.1590/1413-785220182601179926CrossRefPubMedPubMedCentral

24.

Oguz E, Ekinci S, Eroglu M, Bilgic S, Koca K, Durusu M, Kaldirim U, Sadir S, Yurttas Y, Cakmak G, Kilic A, Purtuloglu T, Ozyurek S, Cekli Y, Ozkan H, Sehirlioglu A (2011) Evaluation and comparison of the effects of hyperbaric oxygen and ozonized oxygen as adjuvant treatments in an experimental osteomyelitis model. J Surg Res 171(1):e61–e68. https://doi.org/10.1016/j.jss.2011.06.029CrossRefPubMed

25.

Yasheng T, Mijiti A, Yushan M, Liu Z, Liu Y, Yusufu A (2021) Ozonated water lavage and physiological saline irrigation combined with vacuum-sealed drainage in the treatment of 18 cases of chronic osteomyelitis. J Int Med Res 49(3):300060521999530. https://doi.org/10.1177/0300060521999530CrossRefPubMed

26.

Agrillo A, Ungari C, Filiaci F, Priore P, Iannetti G (2007) Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis. J Craniofac Surg 18(5):1071–1075. https://doi.org/10.1097/scs.0b013e31857261fCrossRefPubMed

27.

Agrillo A, Filiaci F, Ramieri V, Riccardi E, Quarato D, Rinna C, Gennaro P, Cascino F, Mitro V, Ungari C (2012) Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy. Eur Rev Med Pharmacol Sci 16(12):1741–1747PubMed

28.

Ripamonti CI, Cislaghi E, Mariani L, Maniezzo M (2011) Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: preliminary results of a phase I-II study. Oral Oncol 47(3):185–190. https://doi.org/10.1016/j.oraloncology.2011.01.002CrossRefPubMed

29.

Goker F, Donati G, Grecchi F, Sparaco A, Ghezzi M, Rania V, Rossi CA, Del Fabbro M (2020) Treatment of BRONJ with ozone/oxygen therapy and debridement with piezoelectric surgery. Eur Rev Med Pharmacol Sci 24(17):9094–9103. https://doi.org/10.26355/eurrev_202009_22855CrossRefPubMed

30.

Maluf G, Caldas RJ, Fregnani ER, da Silva Santos PS (2019) A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants. Int J Implant Dent 5(1):34. https://doi.org/10.1186/s40729-019-0188-0CrossRefPubMedPubMedCentral

31.

Petrucci MT, Gallucci C, Agrillo A, Mustazza MC, Foà R (2007) Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Haematologica 92(9):1289–1290. https://doi.org/10.3324/haematol.11096CrossRefPubMed

32.

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8(6):e1000412. https://doi.org/10.1371/journal.pbio.1000412CrossRefPubMedPubMedCentral

33.

Hadad H, Kawamata de Jesus L, Piquera Santos AF, Rinaldi Matheus H, Souza Rodrigues LG, Paolo Poli P, Marcantonio Junior E, Pozzi Semeghini Guastaldi F, Maiorana C, Milanezi de Almeida J, Okamoto R, Ávila Souza F (2022) Beta tricalcium phosphate, either alone or in combination with antimicrobial photodynamic therapy or doxycycline, prevents medication-related osteonecrosis of the jaw. Sci Rep 12:16510. https://doi.org/10.1038/s41598-022-20128-4ADSCrossRefPubMedPubMedCentral

34.

Curra, C., Cardoso, C. L., Ferreira, O., Júnior, Curi, M. M., Matsumoto, M. A., Cavenago, B. C., dos Santos, P. L., & Santiago, J. F., Júnior (2016). Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model. Acta Cir Bras, 31(5), 308–313. doi: https://doi.org/10.1590/S0102-865020160050000003

35.

Erdemci F, Gunaydin Y, Sencimen M, Bassorgun I, Ozler M, Oter S, Gulses A, Gunal A, Sezgin S, Bayar GR, Dogan N, Gider IK (2014) Histomorphometric evaluation of the effect of systemic and topical ozone on alveolar bone healing following tooth extraction in rats. Int J Oral Maxillofac Surg 43(6):777–783. https://doi.org/10.1016/j.ijom.2013.12.007CrossRefPubMed

36.

Koçer G, Nazıroğlu M, Çelik Ö, Önal L, Özçelik D, Koçer M, Sönmez TT (2013) Basic fibroblast growth factor attenuates bisphosphonate-induced oxidative injury but decreases zinc and copper levels in oral epithelium of rat. Biol Trace Elem Res 153(1-3):251–256. https://doi.org/10.1007/s12011-013-9659-yCrossRefPubMed

37.

Howie RN, Borke JL, Kurago Z, Daoudi A, Cray J, Zakhary IE, Brown TL, Raley JN, Tran LT, Messer R, Medani F, Elsalanty ME (2015) A model for osteonecrosis of the jaw with zoledronate treatment following repeated major trauma. PloS One 10(7):e0132520. https://doi.org/10.1371/journal.pone.0132520CrossRefPubMedPubMedCentral

38.

Janovszky Á, Szabó A, Varga R, Garab D, Boros M, Mester C, Beretka N, Zombori T, Wiesmann HP, Bernhardt R, Ocsovszki I, Balázs P, Piffkó J (2015) Periosteal microcirculatory reactions in a zoledronate-induced osteonecrosis model of the jaw in rats. Clin Oral Investig 19(6):1279–1288. https://doi.org/10.1007/s00784-014-1347-6CrossRefPubMed

39.

Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25(7):1468–1486. https://doi.org/10.1002/jbmr.141CrossRefPubMed

40.

Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28(1):2–17. https://doi.org/10.1002/jbmr.1805CrossRefPubMed

41.

Awodele O, Olayemi SO, Nwite JA, Adeyemo TA (2012) Investigation of the levels of oxidative stress parameters in HIV and HIV-TB co-infected patients. J Infect Dev Ctries 6(1):79–85. https://doi.org/10.3855/jidc.1906CrossRefPubMed

42.

Lebreton F, van Schaik W, Sanguinetti M, Posteraro B, Torelli R, Le Bras F, Verneuil N, Zhang X, Giard JC, Dhalluin A, Willems RJ, Leclercq R, Cattoir V (2012) AsrR is an oxidative stress sensing regulator modulating Enterococcus faecium opportunistic traits, antimicrobial resistance, and pathogenicity. PLoS Pathog 8(8):e1002834. https://doi.org/10.1371/journal.ppat.1002834CrossRefPubMedPubMedCentral

43.

McDevitt CA, Ogunniyi AD, Valkov E, Lawrence MC, Kobe B, McEwan AG, Paton JC (2011) A molecular mechanism for bacterial susceptibility to zinc. PLoS Pathog 7(11):e1002357. https://doi.org/10.1371/journal.ppat.1002357CrossRefPubMedPubMedCentral

44.

Pacheco VN, Langie R, Etges A, Ponzoni D, Puricelli E (2015) Nitrogen-containing bisphosphonate therapy: assessment of the alveolar bone structure in rats - a blind randomized controlled trial. Int J Exp Pathol 96(4):255–260. https://doi.org/10.1111/iep.12133CrossRefPubMedPubMedCentral

45.

Lopes Castro MM, Nascimento PC, Souza-Monteiro D, Santos SM, Arouck MB, Garcia VB, Araújo RF Jr, de Araujo AA, Balbinot GS, Collares FM, Rosing CK, Monteiro MC, Ferraz Maia CS, Lima RR (2020) Blood oxidative stress modulates alveolar bone loss in chronically stressed rats. Int J Mol Sci 21(10):3728. https://doi.org/10.3390/ijms21103728CrossRefPubMedPubMedCentral

46.

Domazetovic V, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT (2017) Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab 14(2):209–216. https://doi.org/10.11138/ccmbm/2017.14.1.209CrossRefPubMedPubMedCentral

47.

Walter C, Pabst A, Ziebart T, Klein M, Al-Nawas B (2011) Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro. Oral Dis 17(2):194–199. https://doi.org/10.1111/j.1601-0825.2010.01720.xCrossRefPubMed

48.

Gao SY, Zheng GS, Wang L, Liang YJ, Zhang SE, Lao XM, Li K, Liao GQ (2017) Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB. PLoS One 12(6):e0179248. https://doi.org/10.1371/journal.pone.0179248CrossRefPubMedPubMedCentral

49.

T.L. Pires, Efeito da ozonioterapia sistêmica em ratos em uso de bisfosfonato. (2018). 62 f., il. Dissertação (Mestrado em Ciências da Saúde)—Universidade de Brasília, Brasília.

50.

León OS, Menéndez S, Merino N, Castillo R, Sam S, Pérez L, Cruz E, Bocci V (1998) Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm 7(4):289–294. https://doi.org/10.1080/09629359890983CrossRefPubMedPubMedCentral

51.

Okamoto T, de Russo MC (1973) Wound healing following tooth extraction. Histochemical study in rats. Rev Fac Odontol Aracatuba 2(2):153–169PubMed

52.

Okamoto T, Okamoto R, Alves Rezende MC, Gabrielli MF (1994) Interference of the blood clot on granulation tissue formation after tooth extraction. Histomorphological study in rats. Braz Dent J 5(2):85–92PubMed

53.

Broughton G 2nd, Janis JE, Attinger CE (2006) Wound healing: an overview. Plast Reconstr Surg 117(7 Suppl). https://doi.org/10.1097/01.prs.0000222562.60260.f9

54.

Lang M, Zhou Z, Shi L, Niu J, Xu S, Lin W, Chen Z, Wang Y (2016) Influence of zoledronic acid on proliferation, migration, and apoptosis of vascular endothelial cells. Br J Oral Maxillofac Surg 54(8):889–893. https://doi.org/10.1016/j.bjoms.2016.05.030CrossRefPubMed

55.

Pan J, Pilawski I, Yuan X, Arioka M, Ticha P, Tian Y, Helms JA (2020) Interspecies comparison of alveolar bone biology: tooth extraction socket healing in mini pigs and mice. J Periodontol 91(12):1653–1663. https://doi.org/10.1002/JPER.19-0667CrossRefPubMed

56.

Pilawski I, Tulu US, Ticha P, Schüpbach P, Traxler H, Xu Q, Pan J, Coyac BR, Yuan X, Tian Y, Liu Y, Chen J, Erdogan Y, Arioka M, Armaro M, Wu M, Brunski JB, Helms JA (2021) Interspecies comparison of alveolar bone biology, part I: morphology and physiology of pristine bone. JDR Clin Transl Res 6(3):352–360. https://doi.org/10.1177/2380084420936979CrossRef

57.

Hadad H, Matheus HR, Pai SI, Souza FA, Guastaldi FPS (2023) Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes. Arch Oral Biol 159:105875. https://doi.org/10.1016/j.archoralbio.2023.105875CrossRefPubMed

Titel: Ozone therapy effect in medication-related osteonecrosis of the jaw as prevention or treatment: microtomographic, confocal laser microscopy and histomorphometric analysis
verfasst von: Maísa Pereira-Silva
Henrique Hadad
Laís Kawamata de Jesus
Maria Eduarda de Freitas Santana Oliveira
Juliano Milanezi de Almeida
Heloisa Helena Nímia
Osvaldo Magro Filho
Roberta Okamoto
Sérgio Bruzadelli Macedo
Celso Fernando Palmieri Junior
Francisley Ávila Souza
Publikationsdatum: 01.02.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 2/2024
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-024-05547-z

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Ozone therapy effect in medication-related osteonecrosis of the jaw as prevention or treatment: microtomographic, confocal laser microscopy and histomorphometric analysis